Literature DB >> 26505794

Rock2 stabilizes β-catenin to promote tumor invasion and metastasis in colorectal cancer.

Yumin Qiu1, Rongfa Yuan1, Shouhua Zhang2, Leifeng Chen1, Da Huang1, Haibin Hao1, Jianghua Shao3.   

Abstract

Rho-associated coiled-coil-containing protein kinase 2 (Rock2) is an effector for the small GTPase Rho and plays an important role in tumor progression and metastasis. However, the effect of Rock2 in colorectal cancer (CRC) still remains unclear. In this study, we found that Rock2 expression was markedly increased in clinical CRC tissues compared with adjacent non-cancerous tissues. High expression of Rock2 was correlated with tumor metastasis and poor prognosis in CRC. In addition, the knockdown of Rock2 suppressed the invasion and metastasis of CRC cells both in vitro and in vivo. Furthermore, we found that the β-catenin/TCF4 pathway contributed to the effects of Rock2 in CRC cells, and Rock2 stabilized β-catenin by preventing its ubiquitination and degradation. Taken together, this novel pathway for β-catenin control plays a biologically relevant role in CRC metastasis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Invasion; Metastasis; Rock2; β-catenin

Mesh:

Substances:

Year:  2015        PMID: 26505794     DOI: 10.1016/j.bbrc.2015.10.103

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion.

Authors:  Manhua Li; Jing Ke; Qiuhong Wang; Hongyan Qian; Lei Yang; Xunlei Zhang; Jinzhang Xiao; Haifang Ding; Xiaohang Shan; Qingqing Liu; Ying Xiao; Bojun Bao; Hua Huang
Journal:  Clin Exp Med       Date:  2016-12-05       Impact factor: 3.984

2.  miR-106a suppresses tumor cells death in colorectal cancer through targeting ATG7.

Authors:  Haibin Hao; Guangfeng Xia; Chao Wang; Fuping Zhong; Laipeng Liu; Dong Zhang
Journal:  Med Mol Morphol       Date:  2016-12-15       Impact factor: 2.309

3.  Circular RNA circ_HN1 facilitates gastric cancer progression through modulation of the miR-302b-3p/ROCK2 axis.

Authors:  Ding Wang; Xiaohui Jiang; Yi Liu; Guangxin Cao; Xueliang Zhang; Yuting Kuang
Journal:  Mol Cell Biochem       Date:  2020-09-19       Impact factor: 3.396

4.  ROCK2 mediates osteosarcoma progression and TRAIL resistance by modulating O-GlcNAc transferase degradation.

Authors:  Xueqiang Deng; Xuan Yi; Da Huang; Peng Liu; Leifeng Chen; Yunyan Du; Liang Hao
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

5.  TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex.

Authors:  Chen Luo; Rongfa Yuan; Leifeng Chen; Wei Zhou; Wei Shen; Yumin Qiu; Jun Shao; Jinlong Yan; Jianghua Shao
Journal:  Oncotarget       Date:  2017-11-18

6.  Serine protease modulation of Dependence Receptors and EMT protein expression.

Authors:  Kara McNair; Caroline M Forrest; Maria C J Vincenten; L Gail Darlington; Trevor W Stone
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

7.  ROCK2 Promotes Osteosarcoma Growth and Glycolysis by Up-Regulating HKII via Phospho-PI3K/AKT Signalling.

Authors:  Binbin Deng; Jianyong Deng; Xuan Yi; Yeqing Zou; Chen Li
Journal:  Cancer Manag Res       Date:  2021-01-18       Impact factor: 3.989

8.  miR-5590-3p inhibits the proliferation and metastasis of renal cancer cells by targeting ROCK2 to inhibit proliferation, migration and invasion.

Authors:  Queling Liu; Anyi Zhu; Weiyin Gao; Fu Gui; Yan Zou; Xiaocheng Zhou; Zhengdong Hong
Journal:  Oncol Lett       Date:  2022-09-08       Impact factor: 3.111

9.  Overexpression of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Is Correlated with Clinical Progression and Poor Prognosis in Breast Cancer.

Authors:  Hua Yi; Kun Wang; He Jin; Junfang Su; Yidan Zou; Qiao Li; Lina He; Xiaodong Liu; Biaoyan Du
Journal:  Med Sci Monit       Date:  2018-07-10

10.  ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1.

Authors:  Yang Zhou; Yunjiang Zhou; Keke Wang; Tao Li; Minda Zhang; Yunjia Yang; Rui Wang; Rong Hu
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.